Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Invested Capital (2020 - 2025)

Historic Invested Capital for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$2.6 million.

  • Biofrontera's Invested Capital fell 14667.27% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 14667.27%. This contributed to the annual value of $4.4 million for FY2024, which is 4902.84% down from last year.
  • Per Biofrontera's latest filing, its Invested Capital stood at -$2.6 million for Q3 2025, which was down 14667.27% from -$4.7 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Invested Capital peaked at $30.8 million during Q4 2022, and registered a low of -$17.4 million during Q3 2021.
  • Its 5-year average for Invested Capital is $8.8 million, with a median of $8.5 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 24865.94% in 2022, then crashed by 14667.27% in 2025.
  • Quarter analysis of 5 years shows Biofrontera's Invested Capital stood at $14.6 million in 2021, then soared by 111.39% to $30.8 million in 2022, then tumbled by 71.78% to $8.7 million in 2023, then plummeted by 49.03% to $4.4 million in 2024, then crashed by 158.22% to -$2.6 million in 2025.
  • Its Invested Capital was -$2.6 million in Q3 2025, compared to -$4.7 million in Q2 2025 and $500000.0 in Q1 2025.